Phase III PREVENT trial of Cosentyx in nr-axSpA meets 16-week primary endpoint Sep. 17, 2019 No Comments
DSMC recommends continuation of U.S. study of IDCT for degenerative disc disease Sep. 17, 2019 No Comments
FDA grants approval for Taltz as treatment of active ankylosing spondylitis Aug. 27, 2019 No Comments
RSS